Pseudophakic Cystoid Macular Lesions After Uncomplicated Standard Phacoemulsification
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 316
- 主要终点
- Incidence of CMLs
研究概览
简要总结
To assess the incidence, risk factors and clinical courses of cystic macular lesions (CMLs) after uncomplicated phacoemulsification and evaluate the efficacy of topical NSAIDs on the prevention of pseudophakic cystic macular lesions
详细描述
344 Patients undergoing uncomplicated standard phacoemulsification at Kyungpook National University Hospital from 2013 to 2015 were reviewed. CMLs, which is any cystic fluid collections after cataract surgery, were confirmed by preoperative and postoperative optical coherence tomography(OCT) on preoperative, postoperative 1month and 3months examinations. CMLs were classified into two groups: cystic macular edema(CME) and microcystic macular edema(MME).
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •patients who had phacoemulsification and were treated postoperatively at the Kyungpook National University Hospital, Daegu, Korea, from Oct 2013 to June 2015.
排除标准
- •patients had complicated cataract surgery (eg, significant corneal edema, posterior capsule rupture, vitreous loss, dropped nuclear material, retained cortical material, or an IOL not placed in the capsular bag)
研究组 & 干预措施
Treated with topical NSAID
197 eyes of - patients were treated with topical bromfenac sodium hydrate (Bronuck®, Taejoon Pharm. LTD.) 2times a day starting 1 day before surgery and continued for 2 weeks after surgery.
干预措施: topical bromfenac sodium hydrate (Drug)
结局指标
主要结局
Incidence of CMLs
时间窗: 12 weeks
次要结局
未报告次要终点
研究者
Hong Kyun Kim, M.D
Professor
Kyungpook National University Hospital